sk&f 104976 has been researched along with trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride in 1 studies
| Studies (sk&f 104976) | Trials (sk&f 104976) | Recent Studies (post-2010) (sk&f 104976) | Studies (trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride) | Trials (trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride) | Recent Studies (post-2010) (trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride) |
|---|---|---|---|---|---|
| 10 | 0 | 1 | 153 | 0 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busto, R; Cano, S; Dávalos, A; de la Peña, G; Giera, M; Herrera, E; Lasunción, MA; Sánchez-Wandelmer, J | 1 |
1 other study(ies) available for sk&f 104976 and trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride
| Article | Year |
|---|---|
Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes.
Topics: 3T3-L1 Cells; Animals; Caveolae; Caveolin 1; Cell Membrane; Cholesterol; Dehydrocholesterols; Enzyme Inhibitors; G(M1) Ganglioside; Lanosterol; Membrane Microdomains; Mice; Receptor, Insulin; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; Triparanol | 2009 |